Kanada - angličtina - Health Canada

abbvie corporation - ombitasvir; ritonavir; paritaprevir; dasabuvir (dasabuvir sodium monohydrate) - kit - 12.5mg; 50mg; 75mg; 250mg - ombitasvir 12.5mg; ritonavir 50mg; paritaprevir 75mg; dasabuvir (dasabuvir sodium monohydrate) 250mg - hcv polymerase inhibitors

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbvie ltd - ombitasvir; ritonavir; paritaprevir - tablet - 12.5mg ; 50mg ; 75mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbvie ltd - ritonavir; lopinavir - oral solution - 20mg/1ml ; 80mg/1ml

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbvie ltd - ritonavir; lopinavir - tablet - 50mg ; 200mg

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbvie ltd - ritonavir; lopinavir - tablet - 25mg ; 100mg

Izrael - angličtina - Ministry of Health

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - film coated tablets - ritonavir 50 mg; lopinavir 200 mg - lopinavir - lopinavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

Izrael - angličtina - Ministry of Health

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - film coated tablets - ritonavir 50 mg; lopinavir 200 mg - lopinavir - lopinavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

Evropská unie - angličtina - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - ombitasvir, paritaprevir, ritonavir - hepatitis c, chronic - antivirals for systemic use, - viekirax is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults. for hepatitis c virus (hcv) genotype specific activity.,

Saúdská Arábie - angličtina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

abbvie - ombitasvir, paritaprevir, ritonavir - film-coated tablet - 12.5, 50, 75 mg

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - lopinavir, quantity: 100 mg; ritonavir, quantity: 25 mg - tablet, film coated - excipient ingredients: titanium dioxide; polyvinyl alcohol; macrogol 3350; purified talc; colloidal anhydrous silica; iron oxide yellow; copovidone; sorbitan monolaurate; sodium stearylfumarate - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older. this indication is based on the analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled clinical studies (see clinical trials).